Back to top

rsi: Archive

Zacks Equity Research

Down -19.86% in 4 Weeks, Here's Why Magnachip (MX) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Magnachip (MX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MXNegative Net Change

Zacks Equity Research

Down -16.6% in 4 Weeks, Here's Why Perspective Therapeutics (CATX) Looks Ripe for a Turnaround

Perspective Therapeutics (CATX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CATXNegative Net Change

Zacks Equity Research

After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)

Biomea Fusion (BMEA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BMEANegative Net Change

Zacks Equity Research

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)

Kodiak Sciences (KOD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

KODNo Net Change

Zacks Equity Research

Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Cassava Sciences (SAVA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SAVAPositive Net Change

Zacks Equity Research

After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)

Biomea Fusion (BMEA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BMEANegative Net Change

Zacks Equity Research

Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks

The heavy selling pressure might have exhausted for Ginkgo Bioworks (DNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

DNAPositive Net Change

Zacks Equity Research

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)

Inovio (INO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

INONegative Net Change

Zacks Equity Research

After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)

The heavy selling pressure might have exhausted for Biomea Fusion (BMEA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

BMEANegative Net Change

Zacks Equity Research

Infosys (INFY) Loses -9.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Infosys (INFY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

INFYNegative Net Change

Zacks Equity Research

After Plunging -16.57% in 4 Weeks, Here's Why the Trend Might Reverse for Hyliion (HYLN)

Hyliion (HYLN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

HYLNPositive Net Change

Zacks Equity Research

Down -13.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Opera Limited (OPRA)

Opera Limited (OPRA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

OPRAPositive Net Change

Zacks Equity Research

After Plunging -12.12% in 4 Weeks, Here's Why the Trend Might Reverse for AAR (AIR)

AAR (AIR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

AIRPositive Net Change

Zacks Equity Research

Down -19.85% in 4 Weeks, Here's Why Verra Mobility (VRRM) Looks Ripe for a Turnaround

Verra Mobility (VRRM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

VRRMPositive Net Change

Zacks Equity Research

Here's Why Acrivon Therapeutics, Inc. (ACRV) is Poised for a Turnaround After Losing -52.81% in 4 Weeks

Acrivon Therapeutics, Inc. (ACRV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ACRVNo Net Change

Zacks Equity Research

Here's Why Broadcom Inc. (AVGO) is Poised for a Turnaround After Losing -13.05% in 4 Weeks

Broadcom Inc. (AVGO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

AVGOPositive Net Change

Zacks Equity Research

Here's Why Nova Ltd. (NVMI) is Poised for a Turnaround After Losing -19.37% in 4 Weeks

Nova Ltd. (NVMI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NVMIPositive Net Change

Zacks Equity Research

Down -29.7% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround

Genelux Corporation (GNLX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

GNLXNegative Net Change

Zacks Equity Research

Down -34.51% in 4 Weeks, Here's Why You Should You Buy the Dip in Butterfly Network (BFLY)

Butterfly Network (BFLY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BFLYPositive Net Change

Zacks Equity Research

Down -26.43% in 4 Weeks, Here's Why eHealth (EHTH) Looks Ripe for a Turnaround

eHealth (EHTH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

EHTHPositive Net Change

Zacks Equity Research

Down -29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in MBIA (MBI)

MBIA (MBI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

MBIPositive Net Change

Zacks Equity Research

Down -33.89% in 4 Weeks, Here's Why You Should You Buy the Dip in Energy Vault (NRGV)

The heavy selling pressure might have exhausted for Energy Vault (NRGV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

NRGVPositive Net Change

Zacks Equity Research

Down -16.88% in 4 Weeks, Here's Why Standard Motor Products (SMP) Looks Ripe for a Turnaround

Standard Motor Products (SMP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SMPNegative Net Change

Zacks Equity Research

InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

InflaRx (IFRX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

IFRXNegative Net Change

Zacks Equity Research

After Plunging -26.27% in 4 Weeks, Here's Why the Trend Might Reverse for Frontier Group (ULCC)

The heavy selling pressure might have exhausted for Frontier Group (ULCC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ULCCPositive Net Change